Article
Patent protection for CRISPR: an ELSI review
24 Oct 2017
Abstract excerpt
Much has been written about the power of CRISPR—the workhorse genetic-editing system first elucidated in 2012—and the public's interest in it, both as a piece of science and an ethical battleground.1 But there has also been extensive interest in the variety of intellectual property issues surrounding CRISPR, including a heated patent dispute between two of the technology's originators, Jennifer Doudna (UC...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
